Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic SclerosisJacob M. van Laar, A Tyndall, Dominique Farge et al.|JAMA|2014Cited by 739
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working PartyMichael Heuser, Jacqueline Cloos, Sylvie Freeman et al.|Blood|2021Cited by 714
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromesElsa Bernard, Alexandra Smith, Felicitas Thol et al.|Nature Medicine|2020Cited by 633
High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcomeMartine E.D. Chamuleau, G.J. Ossenkoppele, Arjan A. van de Loosdrecht et al.|Haematologica|2008Cited by 99
Aberrant immunophenotype of blasts in myelodysplastic syndromes is a clinically relevant biomarker in predicting response to growth factor treatmentTheresia M. Westers, Arjan A. van de Loosdrecht, Canan Alhan et al.|Blood|2009Cited by 92